Fri, Mar 29, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 2.11% in September (7.29% YTD) as affordable Care Act and demographics boost healthcare sector

Monday, October 14, 2013
Opalesque Industry Update - Hedge funds gained 2.11% in September 2013, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 7.30% year to date.

“The Fed’s decision to delay tapering surprised investors and drove equity prices higher through mid-month,” says Sol Waksman, founder and president of BarclayHedge.

“Fears over the possible failure of US budget and debt ceiling negotiations gained momentum and equity markets sold off in the second half of September, but equities remained profitable on the month as measured by a gain of 5.0 percent for the MSCI World Index.”

All but one of Barclay’s 18 hedge fund indices had gains in September. The Barclay Healthcare & Biotechnology Index jumped 4.26%, Equity Long Bias gained 3.65%, the Technology Index was up 3.35%, Emerging Markets added 2.92%, Pacific Rim Equities gained 2.62%, and European Equities were up 2.03%.

The only losing hedge fund strategy in September was the Equity Short Bias Index, which lost 3.55%. Equity Short Bias is down 19.84% year to date, and the index is on track to match the 24.12% loss suffered in 2012.

After three quarters in 2013, the Healthcare & Biotechnology Index has gained 20.93%. Pacific Rim Equities are up 17.20%, the Equity Long Bias Index has gained 15.24%, Distressed Securities have returned 11.37%, and Technology is up 9.38%.

“Healthcare and Biotechnology is BarclayHedge’s top-performing hedge fund index year to date, and is on track for its best yearly performance since enjoying a 27.91% gain in 2009,” says Waksman.

“The passage of the Affordable Care Act in the US, coupled with the expectation of greater demand for healthcare services due to increases in both population and life expectancy have had a very positive impact on the sector.”

The Barclay Fund of Funds Index gained 1.33% in September, and has returned 4.95% year to date.

Click here to view five years of Barclay Hedge Fund Index data or download 16 years of monthly data.

Press release

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1